Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNS NASDAQ:ESTA NASDAQ:INGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$24.71-0.1%$18.32$9.30▼$24.91$1.16B1.581.07 million shs1.06 million shsESTAEstablishment Labs$69.80+1.0%$64.67$33.35▼$83.31$2.05B1.12515,682 shs279,815 shsINGNInogen$6.80-0.1%$6.56$5.34▼$9.13$184.14M1.64295,571 shs252,800 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-0.04%+0.00%+70.33%+67.43%+93.92%ESTAEstablishment Labs-0.14%-7.43%+9.79%-6.06%+97.60%INGNInogen+1.95%-4.22%+5.58%+17.62%+10.91%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$24.71-0.1%$18.32$9.30▼$24.91$1.16B1.581.07 million shs1.06 million shsESTAEstablishment Labs$69.80+1.0%$64.67$33.35▼$83.31$2.05B1.12515,682 shs279,815 shsINGNInogen$6.80-0.1%$6.56$5.34▼$9.13$184.14M1.64295,571 shs252,800 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-0.04%+0.00%+70.33%+67.43%+93.92%ESTAEstablishment Labs-0.14%-7.43%+9.79%-6.06%+97.60%INGNInogen+1.95%-4.22%+5.58%+17.62%+10.91%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 1.00SellN/AN/AESTAEstablishment Labs 2.63Moderate Buy$87.1424.85% UpsideINGNInogen 2.67Moderate Buy$13.0091.18% UpsideCurrent Analyst Ratings BreakdownLatest AVNS, INGN, and ESTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2026INGNInogen Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)5/7/2026AVNSAvanos Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/7/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$88.00 ➝ $90.005/6/2026ESTAEstablishment Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral4/29/2026ESTAEstablishment Labs BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$88.004/22/2026AVNSAvanos Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/7/2026INGNInogen Freedom CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy3/27/2026ESTAEstablishment Labs Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/11/2026ESTAEstablishment Labs CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$81.00 ➝ $74.002/26/2026ESTAEstablishment Labs Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$85.00 ➝ $90.002/25/2026ESTAEstablishment Labs MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$90.00 ➝ $100.00(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$715.90M1.62$3.42 per share7.22$16.70 per share1.48ESTAEstablishment Labs$229.58M8.95N/AN/A$0.50 per share139.60INGNInogen$348.67M0.53N/AN/A$6.76 per share1.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$72.90M-$1.61N/A26.56N/A-10.39%5.39%3.97%N/AESTAEstablishment Labs-$51.06M-$1.49N/A498.57N/A-19.05%-218.77%-12.31%N/AINGNInogen-$22.75M-$0.91N/AN/AN/A-7.08%-12.90%-8.27%N/ALatest AVNS, INGN, and ESTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2026Q1 2026ESTAEstablishment Labs-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million5/7/2026Q1 2026INGNInogen-$0.24-$0.30-$0.06-$0.30$82.35 million$85.11 million5/5/2026Q1 2026AVNSAvanos Medical$0.16$0.22+$0.06$0.11$170.00 million$182.20 million2/24/2026Q4 2025AVNSAvanos Medical$0.24$0.29+$0.05-$0.03$174.70 million$180.90 million2/24/2026Q4 2025ESTAEstablishment Labs-$0.22-$0.09+$0.13-$0.09$63.80 million$64.62 million2/24/2026Q4 2025INGNInogen-$0.36-$0.26+$0.10-$0.26$82.00 million$81.72 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.112.481.40ESTAEstablishment Labs16.822.962.00INGNInogenN/A3.102.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%ESTAEstablishment Labs72.91%INGNInogen89.94%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.33%ESTAEstablishment Labs9.99%INGNInogen2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,28746.83 million45.73 millionOptionableESTAEstablishment Labs1,00429.43 million26.49 millionOptionableINGNInogen1,03027.08 million26.40 millionOptionableAVNS, INGN, and ESTA HeadlinesRecent News About These CompaniesHow The Inogen (INGN) Story Is Shifting With New Targets And Execution QuestionsMay 12 at 7:29 AM | finance.yahoo.comInogen (NASDAQ:INGN) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPSMay 9, 2026 | marketbeat.comInogen Inc. Earnings Call Highlights Transition PhaseMay 8, 2026 | tipranks.comInogen reaffirms 2026 revenue outlook of $366M-$373M as it scales Aurora and Voxi 5May 8, 2026 | seekingalpha.comInogen, Inc. (INGN) Q1 2026 Earnings Call TranscriptMay 8, 2026 | seekingalpha.comINGN Stock Dips on Q1 Earnings Miss, Sales Up Y/Y, Gross Margin ImprovesMay 8, 2026 | zacks.comInogen Maintains Buy Rating as Analyst Reaffirms $12 Price Target on Solid Q1 and Growth CatalystsMay 8, 2026 | tipranks.comInogen (INGN) Q1 2026 Earnings TranscriptMay 7, 2026 | fool.comInogen Q1 Earnings Call HighlightsMay 7, 2026 | marketbeat.comInogen (INGN) Reports Q1 Loss, Beats Revenue EstimatesMay 7, 2026 | zacks.comInogen Announces First Quarter 2026 Financial ResultsMay 7, 2026 | businesswire.comInogen (INGN) Projected to Post Quarterly Earnings on ThursdayMay 5, 2026 | americanbankingnews.comInogen (INGN) Projected to Post Earnings on ThursdayApril 30, 2026 | marketbeat.comWe're Not Very Worried About Inogen's (NASDAQ:INGN) Cash Burn RateApril 29, 2026 | finance.yahoo.comInogen (NASDAQ:INGN) Stock Price Passes Above 50 Day Moving Average - Here's What HappenedApril 24, 2026 | marketbeat.comInogen to Report First Quarter 2026 Financial Results on May 7, 2026April 24, 2026 | finance.yahoo.comHere's Why You Should Retain Inogen Stock in Your Portfolio for NowApril 22, 2026 | zacks.comInogen Unveils Growth Plan at Needham Conference: New CFO, Voxi 5, Simeox and Aurora Mask PushApril 16, 2026 | marketbeat.comInogen (INGN) Surges 6.9%: Is This an Indication of Further Gains?April 8, 2026 | zacks.comFreedom Broker initiates coverage of Inogen (INGN) with buy recommendationApril 8, 2026 | msn.comInogen Appoints Jamali to Board, Enters Cooperation Agreement With Activist InvestorApril 6, 2026 | marketwatch.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAVNS, INGN, and ESTA Company DescriptionsAvanos Medical NYSE:AVNS$24.70 -0.02 (-0.06%) Closing price 03:59 PM EasternExtended Trading$24.70 0.00 (0.00%) As of 05:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Establishment Labs NASDAQ:ESTA$69.80 +0.72 (+1.04%) Closing price 04:00 PM EasternExtended Trading$69.64 -0.16 (-0.22%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Inogen NASDAQ:INGN$6.80 -0.01 (-0.15%) Closing price 04:00 PM EasternExtended Trading$6.81 +0.01 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
